Clearside Biomedical, Inc. (CLSD)

Clearside Biomedical Statistics

Total Valuation

CLSD has a market cap or net worth of $16.07 million. The enterprise value is $72.14 million.

Market Cap	16.07M
Enterprise Value	72.14M

Important Dates

The last earnings date was Friday, November 7, 2025, after market close.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

CLSD has 5.23 million shares outstanding. The number of shares has increased by 9.72% in one year.

Current Share Class	5.23M
Shares Outstanding	5.23M
Shares Change (YoY)	+9.72%
Shares Change (QoQ)	+0.86%
Owned by Insiders (%)	13.24%
Owned by Institutions (%)	13.56%
Float	4.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.17
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	21.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.98

Current Ratio	2.98
Quick Ratio	2.55
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.17

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-70.35%
Return on Invested Capital (ROIC)	-125.63%
Return on Capital Employed (ROCE)	-258.84%
Revenue Per Employee	$104,031
Profits Per Employee	-$812,375
Employee Count	32
Asset Turnover	0.16
Inventory Turnover	n/a

Taxes

In the past 12 months, CLSD has paid $715,000 in taxes.

Income Tax	715,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -79.33% in the last 52 weeks. The beta is 1.79, so CLSD's price volatility has been higher than the market average.

Beta (5Y)	1.79
52-Week Price Change	-79.33%
50-Day Moving Average	3.99
200-Day Moving Average	9.53
Relative Strength Index (RSI)	35.92
Average Volume (20 Days)	39,228

Short Selling Information

The latest short interest is 84,559, so 1.62% of the outstanding shares have been sold short.

Short Interest	84,559
Short Previous Month	89,833
Short % of Shares Out	1.62%
Short % of Float	1.86%
Short Ratio (days to cover)	2.67

Income Statement

In the last 12 months, CLSD had revenue of $3.33 million and -$26.00 million in losses. Loss per share was -$5.05.

Revenue	3.33M
Gross Profit	2.93M
Operating Income	-22.96M
Pretax Income	-25.28M
Net Income	-26.00M
EBITDA	-22.63M
EBIT	-22.96M
Loss Per Share	-$5.05

Balance Sheet

The company has $6.80 million in cash and $61.61 million in debt, giving a net cash position of -$54.81 million or -$10.47 per share.

Cash & Cash Equivalents	6.80M
Total Debt	61.61M
Net Cash	-54.81M
Net Cash Per Share	-$10.47
Equity (Book Value)	-53.95M
Book Value Per Share	-10.31
Working Capital	5.48M

Cash Flow

In the last 12 months, operating cash flow was -$21.29 million and capital expenditures -$453,000, giving a free cash flow of -$21.75 million.

Operating Cash Flow	-21.29M
Capital Expenditures	-453,000
Free Cash Flow	-21.75M
FCF Per Share	-$4.15

Margins

Gross Margin	88.07%
Operating Margin	-689.76%
Pretax Margin	-759.42%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLSD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.72%
Shareholder Yield	n/a
Earnings Yield	-150.05%
FCF Yield	-125.52%

Analyst Forecast

The average price target for CLSD is $75.00, which is 2,343.00% higher than the current price. The consensus rating is "Hold".

Price Target	$75.00
Price Target Difference	2,343.00%
Analyst Consensus	Hold
Analyst Count	4
Revenue Growth Forecast (5Y)	112.03%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 15, 2025. It was a reverse split with a ratio of 1:15.

Last Split Date	Sep 15, 2025
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	1